PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026Journal of Affective Disorders0 citationsOpen Access

Prenatal antidepressant use and longitudinal differences in BMI up to 8 years of age in the offspring born to mothers with depression/anxiety in the Norwegian Mother, Father and Child Cohort Study

View Full Paper
NTNhung TH TrinhUniversity of OsloSRSina RostamiNorwegian Institute of Public HealthMPMichele PedroncelliUniversity of Oslo

Key Points

  • This study aims to explore the impact of prenatal antidepressant exposure on offspring body mass index (BMI) throughout childhood.
  • Analyzed data from the Norwegian Mother, Father, and Child Cohort Study and the Medical Birth Registry of Norway.
  • Included 6084 pregnancy-child dyads with child BMI data up to 8 years of age.
  • Compared BMI across three groups: continued, discontinued, and unexposed to antidepressants during pregnancy.
  • Used multilevel mixed-effect linear models to analyze BMI differences.
  • Exploratory analyses incorporated parental genetic liability for depression to assess BMI outcomes.
  • Children born to mothers who continued antidepressants had similar BMIs to those who were unexposed.
  • Higher BMI observed in male offspring of mothers continued on SSRIs compared to discontinuers up to age 3.
  • Lower BMI seen in female offspring of continuers versus discontinuers, particularly with low-moderate use of antidepressants.
  • No overall difference in childhood BMI trajectories based on prenatal antidepressant exposure was found.
  • Exploratory analyses indicated sex-specific and potentially genetically influenced BMI differences at certain growth periods.

Abstract

No study has explored how prenatal antidepressant exposure affects offspring body mass index (BMI) throughout childhood. We used data from the Norwegian Mother, Father, and Child Cohort Study (MoBa) linked to the Medical Birth Registry of Norway and the MoBa Genetics. We included 6084 pregnancy-child dyads (singleton, liveborn) with child BMI data up to 8 years, born to women with pre-pregnancy depression/anxiety. Prenatal antidepressant exposure groups include continued antidepressants in pregnancy ( n = 626), discontinued antidepressants proximal to pregnancy ( n = 412), or unexposed to antidepressants ( n = 5046). Mean BMI differences over time between groups were calculated using multilevel mixed-effect linear models. Children born to continuers had comparable childhood BMIs with those born to unexposed mothers or mothers who discontinued antidepressant, in overall and in both sexes. However, higher BMI was observed up to 3 years among male offspring of continued mothers compared to discontinuers in those exposed to selective-serotonin-reuptake-inhibitor before pregnancy (β = 0.334; 95% CI: 0.081 to 0.588 at baseline). Lower BMI was seen among female offspring born to continued vs. discontinued mothers with larger gap over time, especially between low-moderate use of antidepressant vs. discontinuation during pregnancy. Analyses integrating parental genetic liability for depression, BMI, and antidepressant response using polygenic risk scores in ( n = 1913) suggests potential influence of the genetic component on the longitudinal differences in BMI in some strata. The childhood BMI of children born to mothers with pre-pregnancy depression/anxiety did not differ across prenatal antidepressant trajectories. Exploratory analyses revealed differences at specific timeframes which are sex-specific and potentially influenced by genetic liability profiles. • Longitudinal BMI throughout childhood of children born to mothers with pre-pregnancy depression/anxiety does not differ across prenatal antidepressant exposure trajectories. • Exploratory analyses revealed differences at specific times of growth which might be sex-specific and potentially influenced by parental genetic liability profiles.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Trinh et al. (2026) studied this question.

synapsesocial.com/papers/69a91e65d6127c7a504c26e5https://doi.org/10.1016/j.jad.2026.121552
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prenatal antidepressant exposure and longitudinal differences in body mass index up to 8 years of age in the offspring born to mothers with pre-pregnancy depressive and/or anxiety in the Norwegian Mother, Father and Child Cohort Study2024
  2. 2Pre-pregnancy body mass index and offspring neurobehavioral development: a birth cohort study2025
  3. 3Psychosocial Adjustment as a Mediator in the Relationship between Childhood Exposure to Maternal Depression and Subsequent BMI and Overweight Risk2024
  4. 4Influence of gestational weight gain and maternal depression on offspring BMI trajectory from birth to 3 years: A longitudinal mother-infant study2025
  5. 5Parental body mass index and offspring childhood body size and eating behaviour: A structural equation modelling analysis in the Norwegian Mother, Father and Child Cohort Study2026